Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Logan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Bonekey Reports|September 18, 2014
Generation and culture of osteoclastsSilvia Marino, John G Logan, David Mellis, et al.
Cancer Letters|October 3, 2017
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysisSilvia Marino, Ryan T Bishop, John G Logan, et al.
Calcified Tissue International|April 1, 2019
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex VivoSilvia Marino, Ryan T Bishop, Giovana Carrasco, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Quantitative X-Ray Imaging of Mouse Bone by FaxitronNatalie C Butterfield, John G Logan, Julian Waung, et al.
The Journal of Biological Chemistry|July 22, 2015
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced OsteolysisAntonia Sophocleous, Silvia Marino, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysisJohn G Logan, Antonia Sophocleous, Silvia Marino, et al.
The Journal of Biological Chemistry|March 24, 2012
Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signalingPatrick J O'Shea, Dong Wook Kim, John G Logan, et al.
Endocrinology|May 18, 2012
Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast functionJ H Duncan Bassett, John G Logan, Alan Boyde, et al.
European Journal of Endocrinology|February 1, 2014
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal womenApostolos Gogakos, John G Logan, Julian A Waung, et al.
Oncotarget|April 18, 2018
Regulation of breast cancer induced bone disease by cancer-specific IKKβSilvia Marino, Ryan T Bishop, Mattia Capulli, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Bonekey Reports|September 18, 2014
Generation and culture of osteoclastsSilvia Marino, John G Logan, David Mellis, et al.
Cancer Letters|October 3, 2017
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysisSilvia Marino, Ryan T Bishop, John G Logan, et al.
Calcified Tissue International|April 1, 2019
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex VivoSilvia Marino, Ryan T Bishop, Giovana Carrasco, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Quantitative X-Ray Imaging of Mouse Bone by FaxitronNatalie C Butterfield, John G Logan, Julian Waung, et al.
The Journal of Biological Chemistry|July 22, 2015
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced OsteolysisAntonia Sophocleous, Silvia Marino, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysisJohn G Logan, Antonia Sophocleous, Silvia Marino, et al.
The Journal of Biological Chemistry|March 24, 2012
Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signalingPatrick J O'Shea, Dong Wook Kim, John G Logan, et al.
Endocrinology|May 18, 2012
Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast functionJ H Duncan Bassett, John G Logan, Alan Boyde, et al.
European Journal of Endocrinology|February 1, 2014
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal womenApostolos Gogakos, John G Logan, Julian A Waung, et al.
Oncotarget|April 18, 2018
Regulation of breast cancer induced bone disease by cancer-specific IKKβSilvia Marino, Ryan T Bishop, Mattia Capulli, et al.
Pageof 3